Active, fundamental investors
Our integrated, disciplined and high-conviction investment process tends to result in portfolios with high active shares. In contrast to ETF and passive investors, we direct our resource towards fundamental analysis and being on the right side of change. Strong access to company management helps to drive non-consensus views.
Unless specifically stated, environmental, social and governance (ESG) is an integrated, but non-binding, input into our investment process. We actively assess individual company ESG performance and risk factors. In conjunction with our Global Responsible Investment (GRI) team we continually engage with companies to promote positive change and monitor the long-term value of our investments. We do, however, also offer sustainable investment solutions where portfolio decisions are dictated by certain sustainability criteria.
Our investment advantage.
Equity markets tend to be inefficient at pricing companies that are facing or undergoing significant change in their business or operating environment. We seek to exploit this by investing in stocks where the positive or negative implication of change are mispriced regardless of style characteristics.
A common investment language embedded across all regions and sectors facilitates the delivery of sharp and effective connected thinking. Enhanced by direct company contact and integrated information flows from GRI, macro, multi-asset, credit teams, our process ensures all relevant investment information is surfaced when making each stock selection decision.
For further information on the risks and risk profiles of our funds, please refer to the relevant fund documents.
The value of an investment and any income from it can go down as well as up and can fluctuate in response to changes in currency and exchange rates. Investors may not get back the original amount invested.
Need more information?
For further information, please contact our investment sales team.
Strategies in focus
Where the wild things are: Why investors should care about natural capital
14 Dec. 2021
Finance must wake up to the risks associated with biodiversity loss and the opportunities that arise from nature-friendly solutions, argue Eugenie Mathieu, Julie Zhuang and Jonathan Toub.
The future of pharma: Increased returns or the age of biotech?
8 Dec. 2021
After decades of low returns on research and development (R&D), the healthcare sector is producing a slew of innovations, from drugs to diagnostics. But with many coming from new entrants, will big pharmaceutical companies manage to keep up with the times?
The long decline: Why trend economic growth is set to go on falling
12 Nov. 2021
Trend rates of economic growth, which have been on the decline for decades in the world’s leading economies, look set to fall further. That will have big implications for governments, companies, households and investors, argues Stewart Robertson.
Regulatory shifts in China: A new fork in the road?
12 Oct. 2021
Investors in China should view recent interventions by the government in the context of its history and longer-term strategic ambitions, argues Amy Kam.
The AIQ Podcast: China's tech crackdown
21 Sep. 2021
China’s regulators are taking swift, radical action against tech companies they consider to be too big and powerful. How should foreign investors respond?
Are bond investors too complacent about inflation?
11 Aug. 2021
US Treasury yields have fallen appreciably in recent weeks, seemingly dismissing the threat of rising consumer prices. Some investors could be in for a nasty surprise if inflation proves more intransigent than anticipated, argue Michael Grady and Katarina Cohrs.
Investors should confront the dark side of tech
9 Jul. 2021
Technology firms are often favoured by ESG funds because of their ostensibly clean, asset-light business models. But investors need to look deeper and challenge unethical and unsustainable practices across the industry, argue Louise Piffaut and Charles Devereux.
China’s Big Tech crackdown
5 Jul. 2021
Like Washington and Brussels, Beijing is worried about the growing power of large technology companies. But China’s regulators are taking swifter, more radical action than their peers in the West.
The Anti-Social Network
2 Jul. 2021
Facebook, Twitter and other platforms are drawing criticism for their failure to tackle hate content. But will the hit to their reputation do any lasting commercial damage?
The taming of the few
1 Jul. 2021
Regulatory authorities around the world are targeting the big US tech giants. However, while investors need to keep a watchful eye on developments, Big Tech’s stranglehold and influence on numerous economic sectors will be hard to loosen.
Is there now ‘value’ in value investing?
2 Jun. 2021
Value or growth? It is an age-old debate and, as Giles Parkinson argues, a slightly irrelevant one given the changing makeup of the economy and the gentle decoupling of intrinsic value from financial statements.
Green is not always clean: Rising tide of greenwash brings risks for investors
19 May 2021
Some companies have long sought to mislead the public about their commitments to sustainability, but greenwashing has become more widespread and sophisticated in recent years. Now regulators and investors are fighting back.
How COVID-19 is accelerating the use of new technologies in construction and manufacturing
14 May 2021
During the pandemic, companies have stepped up investments in technology to communicate remotely with customers and keep their businesses running. As well as boosting efficiency and profitability, it also creating investment opportunities in previously overlooked areas.
Flipside: Not all externalities are negative
4 May 2021
ESG factors have long been viewed as risk factors to manage. Giles Parkinson explores the flipside of this proposition, contending that positive externalities are an under-leveraged investment opportunity.
What does the data say? Vaccines, illiquidity and managers called Dave
26 Mar. 2021
In the first of a new monthly series, we take a visual approach to illustrate topical data themes in economies, markets and beyond. This month we look at the correlation between stock market performance and vaccinations, the illiquidity premium in real assets, and whether there are still more men called Dave running funds than female managers.
Why it is getting harder to assess value in financial markets
19 Mar. 2021
Massive intervention by central banks and governments in recent years has left investors struggling to value financial assets.